Importantly, using previously established xenograft-derived metastatic HNSCC cell lines [34, 35], we demonstrated that the expressions of S100A4 and, to less extend, the Nanog, are increased during the acquisition of metastatic phenotype (Supplementary Figure S2). The gene discussed is S100A4; the disease is head and neck squamous cell carcinoma.